$DXCM SEC Filings

Filed On	Filing
19 Oct 2026	Form 4: Brown Michael Jon, EVP Chief Legal Compliance Off Sold 1,700 shares ($145K)
15 Oct 2026	144
30 Sep 2026	Form 4: Stern Sadie, EVP Chief People & Culture Off Sold 2,565 shares ($221K)
28 Sep 2026	144
16 Sep 2026	Form 4: Augustinos Nicholas, Director Sold 1,550 shares ($130K) · Sold 6,539 shares ($550K)
16 Sep 2026	Form 4: Brown Michael Jon, EVP Chief Legal Compliance Off Sold 1,700 shares ($143K)
15 Sep 2026	144
15 Sep 2026	144
14 Sep 2026	144
14 Sep 2026	Form 4: Sylvain Jereme M, EVP, Chief Financal Officer Sold 3,638 shares ($303K)
14 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure SAN DIEGO - (BUSINESS WIRE- September 14, 2026) - DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the promotion of Jereme Sylvain to the role of Chief Operating Officer (COO) in addition to his duties...
10 Sep 2026	144
10 Sep 2026	Form 4: Boehnlein Glenn S, Director Received 5,841 shares as a grant or award
10 Sep 2026	Form 3: Boehnlein Glenn S, Director Holds 42 shares of Common Stock
10 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure SAN DIEGO - (BUSINESS WIRE- September 10, 2026) - DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026.
28 Aug 2026	Form 4: Stern Sadie, EVP Chief People & Culture Off Sold 2,565 shares ($227K)
27 Aug 2026	144
25 Aug 2026	Form 4: Leach Jacob Steven, Director Gave up 1,451 shares to cover exercise price or tax ($134K)
25 Aug 2026	Form 4: Sylvain Jereme M, EVP, Chief Financal Officer Gave up 1,451 shares to cover exercise price or tax ($134K)
25 Aug 2026	Form 4: Brown Michael Jon, EVP Chief Legal Compliance Off Gave up 1,451 shares to cover exercise price or tax ($134K)

Comments